Person: ŞEKER, MESUT
75 results
Search Results
Now showing 1 - 10 of 75
Publication Metadata only The effect of tumor size on overall survival in patients with pT3 gastric cancer: experiences from 3 centers.(2010-01-01T00:00:00Z) BILICI, A; UYGUN, K; Seker, MESUT; USTAALIOĞLU, BB; ALIUSTAOGLU, M; TEMIZ, S; AKSU, G; GEZEN, C; YAVUZER, D; KAYA, S; SALEPCI, T; MAYADAGLI, ALPASLAN; GUMUS, M; ŞEKER, MESUT; MAYADAĞLI, ALPASLANPublication Metadata only The importance of multifocal/multicentric tumor on the disease-free survival of breast cancer patients: single center experience.(2012-12-01T00:00:00Z) USTAALIOGLU, BO; BILICI, A; KEFELI, U; Şeker, MESUT; ONCEL, M; GEZEN, C; GUMUS, M; DEMIRELLI, F; ŞEKER, MESUTPublication Metadata only Clinicopathological features of gastroenteropancreatic neuroendocrine neoplasms: a retrospective single-center experience(2021-03-01T00:00:00Z) ŞEKERCİ, ABDÜSSELAM; TÜRK, HACI MEHMET; DEMİR, Tarık; ŞEKER, Mesut; AKÇAKAYA, Adem; ARICI, Dilek Sema; ŞEKERCİ, ABDÜSSELAM; TÜRK, HACI MEHMET; DEMİR, TARıK; ŞEKER, MESUT; AKÇAKAYA, ADEM; ARICI, DILEK SEMAPublication Metadata only Important factors affecting adjuvant treatment decision in stage IA breast cancer patients in Turkey(2014-01-01T00:00:00Z) OVEN USTAALIOGLU, Bala B.; Bilici, Ahmet; YILMAZ, Burçak E.; ALIUSTAOGLU, Mehmet; Seker, MESUT; VARDAR, Fugen; Gümüş, Mahmut; ŞEKER, MESUTPublication Metadata only Evaluation of kidney functions in patients on chemotherapy(2019-07-23) Kazancıoğlu, Rümeyza; Elçioğlu, Ömer Celal; Gürsu, Meltem; Artan, Ayşe Serra; Şeker, Mesut; Türk, Hacı Mehmet; Haziyev, Elgun; KAZANCIOĞLU, RÜMEYZA; ELÇİOĞLU, ÖMER CELAL; GÜRSU, MELTEM; ARTAN, AYŞE SERRA; ŞEKER, MESUT; TÜRK, HACI MEHMETPublication Metadata only The association of pre-treatment peripheral blood markers with survival in patients with pancreatic cancer.(2010-05-01T00:00:00Z) ALIUSTAOGLU, M; BILICI, A; Seker, MESUT; DANE, F; GOCUN, M; KONYA, V; USTAALIOĞLU, BB; GUMUS, M; ŞEKER, MESUTPublication Metadata only Prognostic Factors for Operated Gallbladder Cancer.(2019-09-01T00:00:00Z) Oven, Ustaalioglu; Bilici, A; Seker, MESUT; Kefeli, U; Aydin, D; Celik, S; Demir, T; Erkol, B; ŞEKER, MESUTPublication Metadata only Correlation of Caveolin-1 Expression with Prognosis in Patients with Gastric Cancer after Gastrectomy(2017-04-01) Seker, MESUT; AYDIN, Dincer; Bilici, Ahmet; YAVUZER, Dilek; OZGUN, Melin G.; OZCELIK, Melike; AYDIN, Ozhan; ALIUSTAOGLU, Mehmet; ŞEKER, MESUTBackground: Upregulation of caveolin-1 (Cav-1) expression is correlated with histopathological grade and poor prognosis in several human cancers. However, in gastric cancer, its clinical utility as a useful prognostic molecular marker remains unclear. Methods: The prognostic importance of Cav-1 expression was retrospectively analyzed by immunohistochemistry in 148 patients with gastric cancer who had undergone radical gastrectomy. Results: Cav-1 expression was positive in 23 (15.5%) patients and negative in 125 (84.5%) patients. Tumor location, tumor grade, lymph node involvement, pT stage, pTNM stage, and the presence of recurrence were found to be significantly associated with Cav-1 expression. The median disease-free survival (DFS) of patients with negative Cav-1 expression was significantly better than that of patients with positive Cav-1 expression (not reached vs. 10.2 months, p < 0.001). Moreover, patients with positive Cav-1 expression had a worse median overall survival (OS) compared to patients with negative Cav-1 expression (14.2 vs. 40.3 months, p = 0.004). In the multivariate analysis, Cav-1 expression (positive vs. negative) was an independent prognostic factor for DFS (p < 0.001, hazard ratio (HR) 2.58) and OS (p = 0.031, HR 1.87), as was lymph node metastasis. Conclusion: Our results suggest that positive Cav-1 expression is associated with progression and poor prognosis in gastric cancer patients after radical gastrectomy. Targeting Cav-1 would be a potential option for future gastric cancer treatment. (C) 2017 S. Karger GmbH, FreiburgPublication Metadata only A case of metastatic breast cancer successfully treated with lapatinib plus capecitabine therapy.(2011-02-01T00:00:00Z) KEFELI, U; BILICI, A; USTAALIOĞLU, BB; KEFELI, AU; YILDIRIM, MEHMET ŞİRİN; Seker, MESUT; GUMUS, M; YILDIRIM, MEHMET ŞİRİN; ŞEKER, MESUTPublication Metadata only Malignancies diagnosed during pregnancy and treated with chemotherapy or other modalities (review of 27 cases): multicenter experiences.(2010-07-01T00:00:00Z) Anatolian, Medical; USTAALIOĞLU, BB; GUMUS, M; UNAL, ABDULLAH SALİH; CAYIR, K; SEVER, O; BILICI, A; ELKIRAN, ET; KARACA, H; BENEKLI, M; KARAOGLU, A; Seker, MESUT; ÜNAL, ABDULLAH SALİH; ŞEKER, MESUT